JP
Jana Partners Portfolio holdings
AUM
$1.34B
This Quarter Return
+8.79%
1 Year Return
+5.03%
3 Year Return
+36.04%
5 Year Return
+55.17%
10 Year Return
+178.84%
AUM
$4.77B
AUM Growth
+$4.77B
(+13%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
6.94%
Top 10 Holdings %
Top 10 Hldgs %
63.89%
Holding
64
New
22
Increased
9
Reduced
11
Closed
16
Top Buys
| 1 |
TIF
Tiffany & Co.
TIF
|
$541M |
| 2 |
WFM
Whole Foods Market Inc
WFM
|
$424M |
| 3 |
DuPont de Nemours
DD
|
$226M |
| 4 |
Sherwin-Williams
SHW
|
$203M |
| 5 |
Liberty Media Series C
FWONK
|
$136M |
Top Sells
| 1 |
Conagra Brands
CAG
|
$458M |
| 2 |
HDS
HD Supply Holdings, Inc.
HDS
|
$348M |
| 3 |
TMH
Team Health Holdings Inc
TMH
|
$256M |
| 4 |
Bristol-Myers Squibb
BMY
|
$172M |
| 5 |
TransDigm Group
TDG
|
$145M |
Sector Composition
| 1 | Consumer Staples | 14.42% |
| 2 | Communication Services | 12.73% |
| 3 | Financials | 12.56% |
| 4 | Healthcare | 12.55% |
| 5 | Materials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
TransDigm Group
TDG
$72B
| – | – |
-581,211
| Closed | -$145M |
|
52
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
|
SAGE
53
DELISTED
Sage Therapeutics
SAGE
| – | – |
-198,406
| Closed | -$10.1M |
|
54
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
-128,121
| Closed | -$9.01M |
|
55
Puma Biotechnology
PBYI
$258M
| – | – |
-142,727
| Closed | -$4.38M |
|
56
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-181,296
| Closed | -$7.02M |
|
57
McKesson
MCK
$85.9B
| – | – |
-386,868
| Closed | -$54.3M |
|
58
Mattel
MAT
$5.87B
| – | – |
0
| – | – |
|
59
Lamb Weston
LW
$7.88B
| – | – |
-1,858,373
| Closed | -$70.3M |
|
60
L3Harris
LHX
$51.1B
| – | – |
-1,103,024
| Closed | -$113M |
|
61
Incyte
INCY
$17B
| – | – |
-86,616
| Closed | -$8.69M |
|
62
Illumina
ILMN
$15.2B
| – | – |
0
| – | – |
|
63
Dell
DELL
$83.9B
| – | – |
-750,000
| Closed | -$41.2M |
|
64
AbbVie
ABBV
$374B
| – | – |
0
| – | – |
|